Stability and equilibria of promiscuous aggregates in high protein milieus
- 2 January 2007
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Molecular BioSystems
- Vol. 3 (3) , 208-213
- https://doi.org/10.1039/b616314a
Abstract
At micromolar concentrations, many molecules form aggregates in aqueous solution. In this form, they inhibit enzymes non-specifically leading to false positive “hits” in enzyme assays, especially when screened in high-throughput. This inhibition can be attenuated by bovine serum albumin (BSA); the mechanism of this effect is not understood. Here we present evidence that BSA, lysozyme, and trypsin prevent inhibition when incubated at milligram per millilitre concentrations with aggregates prior to the addition of the monitored enzyme. These solutions still contained aggregates by dynamic light scattering (DLS), suggesting that inhibition is prevented by saturating the aggregate, rather than disrupting it. For most combinations of aggregate and protein, inhibition was not reversed if the competing protein was added after the incubation of aggregates with the monitored enzyme. In the one exception where modest reversal was observed, DLS and flow cytometry indicated that the effect was due to the disruption of aggregates. These results suggest that aggregate-bound enzyme is not in dynamic equilibrium with free enzyme and that bound enzyme cannot be displaced by a competing protein. To further test this hypothesis, we incubated aggregate-bound enzyme with a specific, irreversible inhibitor and then disrupted the aggregates with detergent. Most enzyme activity was restored on aggregate disruption, indicating no modification by the irreversible inhibitor. These results suggest that enzyme is bound to aggregate so tightly as to prevent any noticeable dissociation and that furthermore, aggregates are stable at physiologically relevant concentrations of protein.Keywords
This publication has 23 references indexed in Scilit:
- Avoiding physicochemical artefacts in early ADME–Tox experimentsDrug Discovery Today, 2006
- Hit discovery and hit-to-lead approachesDrug Discovery Today, 2006
- Screening in a spirit haunted worldDrug Discovery Today, 2006
- High-throughput assays for promiscuous inhibitorsNature Chemical Biology, 2005
- Detailed Kinetic Studies of an Aggregating Inhibitor; Inhibition of Phosphomannomutase/Phosphoglucomutase by Disperse Blue 56Biochemistry, 2004
- Identification and Prediction of Promiscuous Aggregating Inhibitors among Known DrugsJournal of Medicinal Chemistry, 2003
- Designing screens: how to make your hits a hitNature Reviews Drug Discovery, 2003
- Kinase Inhibitors: Not Just for Kinases AnymoreJournal of Medicinal Chemistry, 2003
- Development of a Virtual Screening Method for Identification of “Frequent Hitters” in Compound LibrariesJournal of Medicinal Chemistry, 2001
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000